查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1776209

球囊导管的全球市场:洞察，竞争情形，市场预测:2032年

Balloon Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2024年，球囊导管市场规模为49.7201亿美元。预计到2032年，该市场规模将达到89.2876亿美元，2025年至2032年的复合年增长率为7.63%。心血管疾病、脑动脉瘤和骨盆腔癌的发生率不断上升，大大推动了球囊导管市场的发展。随着心血管疾病的日益普遍，对球囊导管的需求也日益增长。球囊导管对于治疗脑动脉瘤和增强骨盆腔癌的药物传递也至关重要。同时，主要市场参与者的产品开发正在推动药物洗脱球囊和生物可吸收球囊等创新技术的出现。这些因素共同推动了球囊导管市场的发展，因为医疗保健提供者正在寻求有效的解决方案来满足不同患者群体的临床需求。预计这些综合因素将在2025年至2032年的预测期内推动球囊导管市场的发展。

球囊导管市场动态：

根据英国心臟基金会（British Heart Foundation）的最新数据（2025年），全球约有6.4亿人患有心臟和循环系统疾病，约每12人中就有1人患有此类疾病。英国心臟基金会（British Heart Foundation）的进一步数据（2024年）表明，冠状动脉（缺血性）心臟病是全球最常见的心血管疾病，影响约2亿人，其中包括约1.1亿男性和8,000万名女性。此外，全球约有5600万女性和4500万男性中风后存活下来。此外，至少有1,300万人患有先天性心臟病，还有数百万人可能尚未确诊。

全球心血管疾病（包括冠状动脉疾病、週边动脉疾病和中风）的盛行率不断上升，推动了对有效微创干预措施的需求。经皮腔内冠状动脉成形术 (PTCA) 就是这样一种干预措施，它使用球囊导管打开狭窄或阻塞的动脉并恢復血流，从而降低心臟病发作和中风的风险。随着心血管疾病负担的持续加重，预计 PTCA 和 PCI 手术的数量将会增加，这将直接推动对 PTCA 球囊导管的需求并支持市场扩张。

除了心血管应用外，球囊导管在管理癌症相关併发症方面也发挥着重要作用。根据 GLOBOCAN (2022) 的数据，预计全球肾癌新病例约为 43.5 万例，到 2045 年将增至 69.3 万例。同样，膀胱癌新发病例估计在 2022 年为 61.4 万例，预计到 2045 年将达到 112 万例。骨盆腔癌会阻塞输尿管，阻碍尿液从肾臟流向膀胱，导致尿液滞留和肾臟损伤。在这种情况下，通常会进行肾造口术，通常会使用肾造口球囊导管建立尿液引流通道。随着骨盆腔癌发病率的上升，预计对球囊导管的需求将增加，进一步推动全球球囊导管市场的成长。 此外，持续的产品创新和监管审批正在推动市场发展。例如，2024年7月，泰利福公司（Teleflex Incorporated）的Ringer™灌注球囊导管（PBC）获得了FDA 510(k)批准，这是目前唯一一款市售的PTCA灌注球囊导管。此球囊导管采用快速交换设计，其螺旋球囊在充气后会变成空心，即使在长时间球囊扩张期间也能维持冠状动脉血流。它用于扩张冠状动脉狭窄部位以及需要远端灌注的旁路移植术。

然而，市场也面临挑战。与球囊导管手术相关的风险，例如动脉剥离、血管穿孔和栓塞，可能导致严重的併发症。此外，由于品质和安全问题导致的产品召回事件增多，可能会阻碍未来的市场成长。

由于心血管疾病和癌症发病率的上升以及技术创新的进步，全球球囊导管市场预计将实现显着增长。然而，持续关注器械安全性和品质对于维持长期市场扩张至关重要。

球囊导管市场区隔分析：

预计到2024年，非顺应性球囊导管类别将占据以球囊类型划分的球囊导管市场的最大占有率。非顺应性球囊能够保持其形状和大小，从而能够更可预测和控制地扩张狭窄或阻塞的血管。这项特性使其在高压应用中特别有利，例如冠状动脉疾病的治疗，在这种应用中，精确的球囊尺寸对于获得最佳疗效且不损伤周围组织至关重要。非顺应性球囊的卓越性能可降低血管成形术等手术中发生球囊破裂和血管创伤等併发症的风险，从而获得更好的治疗效果。随着医疗保健提供者越来越认识到这些专用球囊导管的优势，对非顺应性球囊导管的需求也不断增长。

此外，材料技术和设计的进步使非顺应性球囊更加有效且用途广泛，从而推动了其在各个医疗领域的应用。这种向非顺应性球囊导管的转变不仅提高了手术成功率，也推动了整个球囊导管市场的发展。例如，2023年9月，Kossel Medtech的Sabelly®非顺应性週边球囊扩张导管获得了中国国家药品监督管理局的市场批准。此导管专为週边血管成形术设计，是首个经批准的国产大直径球囊导管，有助于减少对进口产品的依赖。

因此，预计该细分市场的收入将在预测期内大幅成长，从而推动全球球囊导管市场的整体成长。

预计北美将主导整个球囊导管市场：

在所有地区中，预计到2024年，北美将占据全球球囊导管市场的最大占有率。球囊导管市场的主要推动因素包括：生活方式相关疾病的盛行率不断上升，这些疾病导致脑动脉瘤、膀胱癌、良性前列腺增生和尿潴留等泌尿系统疾病以及各种心血管疾病的发生；以及该地区对产品开发的日益重视。这些因素共同作用，预计将推动该地区整个球囊导管市场的发展。

根据美国心臟协会（2023年）发布的数据，美国每年进行超过50万例经皮冠状动脉介入治疗，其中经皮腔内冠状动脉成形术占很大比例。因此，心血管疾病盛行率的上升以及随之而来的PCI手术的增加预计将进一步推动对刻划和切割球囊导管的需求。据估计，这将有助于北美球囊导管市场的成长。

脑动脉瘤盛行率的上升也促进了北美球囊导管市场的成长。根据脑动脉瘤基金会（2023年）的统计数据，美国每年约有3万人患有脑动脉瘤破裂。美国癌症协会的单独数据估计，2023年美国将有约24,350例脑部或脊髓恶性肿瘤。此外，据估计，2023年美国将有约18,600人死于脑部或脊髓肿瘤。这些适应症通常使用闭塞球囊导管治疗，这种导管专门设计用于神经血管系统的给药。因此，脑动脉瘤盛行率的上升也有望推动球囊导管需求，并支持北美球囊导管市场的成长。

此外，整个地区的产品开发活动也有望推动该地区整体球囊导管市场的发展。例如，2023年8月，上海微创医疗（MicroPort® Coronary）的Firefighter™ NC Pro PTCA球囊导管获得美国食品药物管理局（FDA）批准。这款新一代高压球囊专为扩张狭窄冠状动脉和支架置入术后手术而设计。其三层复合球囊和高达22个大气压的爆破压力可有效治疗钙化等顽固性病变。

因此，预计上述因素将在预测期内推动该地区北美球囊导管市场的发展。

球囊导管市场的主要参与者

球囊导管市场的主要公司包括美敦力、波士顿科学公司、雅培、库克、B. Braun Melsungen AG、康德乐、泰尔茂公司、史赛克、泰利福公司、微创科学公司、百多力、尼普洛医疗公司、BD、康乐保、Summit Medical（Innovia Medical）、百多力、尼普洛医疗公司、BD、康乐保、Summit Medical（Innovia Medical）、威普威特医疗有限公司（北京科技有限公司）。

球囊导管市场的最新发展：

  • 2024 年 3 月，波士顿科学公司宣布 FDA 批准 AGENT™ 药物涂层球囊 (DCB) 导管，用于治疗冠状动脉疾病患者的冠状动脉支架内再狭窄 (ISR)。疾病。
  • 2022年5月，美敦力宣布美国食品药物管理局 (FDA) 批准了IN.PACT 018紫杉醇涂层经皮腔内血管成形术 (PTA) 球囊导管，这是一种药物涂层球囊 (DCB)，适用于介入治疗股浅动脉和腘动脉的外周动脉疾病 (PAD)。

球囊导管市场研究报告主要内容

  • 目前球囊导管市场规模分析（2024 年）及八年市场预测（2025-2032 年）
  • 过去三年主要产品/技术发展、併购、合作及合资企业
  • 主导球囊导管市场的主要公司
  • 球囊导管市场中的竞争对手的商业机会
  • 2024 年的主要细分市场及其 2030 年的表现
  • 目前球囊导管市场的主要地区和国家
  • 企业应关注哪些地区和国家以把握未来球囊导管市场的成长机会

球囊导管市场相关常被询问的问题

1.球囊导管

  • 球囊导管是一种尖端连接有球囊的柔性导管。此类导管用于各种微创诊断和治疗操作，例如疏通阻塞、扩张血管和置入支架。

2. 球囊导管市场

  • 预计2024年球囊导管市场价值将达到49.7201亿美元，预计2025年至2032年期间的复合年增长率为7.63%，到2032年将达到89.2876亿美元。

3. 球囊导管市场的推动因素

  • 心血管疾病、脑动脉瘤和骨盆腔癌盛行率的上升显着推动了球囊导管市场的发展。随着心血管疾病的日益普遍，对球囊导管的需求也不断增加。球囊导管对于治疗脑动脉瘤和增强骨盆腔癌的药物传递也至关重要。同时，主要市场参与者在产品开发的进步，催生了药物洗脱球囊和生物可吸收球囊等创新技术。这些因素共同推动了球囊导管市场的发展，因为医疗保健提供者正在寻求有效的解决方案来满足日益多样化的患者群体的临床需求。预计在2025年至2032年的预测期内，这些因素将推动球囊导管市场的发展。

4.球囊导管市场的主要参与者

  • 球囊导管市场的主要公司包括美敦力、波士顿科学公司、雅培、库克、B. Braun Melsungen AG、康德乐、泰尔茂公司、史赛克、泰利福公司、微创科学公司、百多力、尼普洛医疗公司、BD、康乐保、Summit Medical（Innovia Medical Medical）、百多力、尼普洛医疗公司、BD、康乐保、Summit Medical（Innovia Medical）、威普威特医疗有限公司（北京科技有限公司）。

5.球囊导管市占率最大的地区

  • 在所有地区中，预计北美将在2024年占据全球球囊导管市场的最大占有率。球囊导管市场的主要推动因素包括：生活方式相关疾病的盛行率不断上升，导致脑动脉瘤、膀胱癌、良性前列腺增生、尿潴留等泌尿系统疾病以及各种心血管疾病的发生；以及该地区对产品开发活动的日益重视。这些因素预计将推动该地区整体球囊导管市场的发展。

目录

第1章 球囊导管市场报告的简介

第2章 球囊导管市场摘要整理

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 球囊导管市场主要原因分析

  • 球囊导管推动市场要素
    • 心血管疾病盛行率上升
    • 脑动脉瘤发生率上升
    • 骨盆腔癌发生率上升
    • 全球主要市场参与者的产品开发活动
  • 球囊导管市场的限制与挑战
    • 球囊导管相关的手术风险
    • 产品召回不断增加
  • 球囊导管市场机遇
    • 球囊导管安全展望及设计缺陷的持续改进

第6章 球囊导管市场:波特的五力分析

第7章 球囊导管市场评估

  • 各产品类型
    • PTA球囊导管
    • PTCA球囊导管
    • 闭塞球囊导管
    • 导尿管
    • 肾瘘球囊导管
    • 药物释放型导管
    • 其他
  • 导管类型
    • 固定线
    • OTW
    • 快速交换导管
  • 气球类型
    • 不兼容
    • 半兼容
    • 顺应性导管
  • 各终端用户
    • 医院
    • 专门诊所
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 球囊导管市场企业与产品简介

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Cook
  • B. Braun Melsungen AG
  • Cardinal Health
  • Terumo Corporation
  • Stryker
  • Teleflex Incorporated
  • Microport Scientific Corporation
  • BIOTRONIK
  • Nipro Medical Corporation
  • BD
  • Coloplast
  • Summit Medical (Innovia Medical)
  • Well Lead Medical Co., Ltd.
  • Smiths Medical
  • BACTIGUARD AB
  • JOTEC GmbH
  • Lepu Medical Technology(Beijing)Co.,Ltd.

第9章 KOL的见解

第10章 计划方法

第11章 关于DelveInsight

第12章 免责声明和咨询方式

Product Code: DIMDCL0314

Balloon Catheters Market by Product Type (PTA, PTCA, Occlusion, Foley, Nephrostomy, Drug-Eluting, and Others), Catheter Type (Fixed Wire, Over-The-Wire, and Rapid Exchange), Balloon Type (Non-Compliant, Semi-Compliant, and Compliant), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising prevalence of cardiovascular diseases, growing prevalence of brain aneurysms, increasing prevalence of cancers in the pelvic region, and increase in product development activities by key market players across the globe.

The balloon catheters market was valued at USD 4,972.01 million in 2024, growing at a CAGR of 7.63% during the forecast period from 2025 to 2032, to reach USD 8,928.76 million by 2032. The rising prevalence of cardiovascular diseases, brain aneurysms, and pelvic region cancers is significantly boosting the market for balloon catheters. As cardiovascular conditions become more common, the demand for balloon catheters increases. Additionally, balloon catheters are vital in managing brain aneurysms and enhancing drug delivery in pelvic cancers. Concurrently, advancements in product development by key market players are leading to innovative technologies, such as drug-eluting and bioresorbable balloons. These combined factors are driving the balloon catheter market as healthcare providers seek effective solutions to address the growing clinical needs of diverse patient populations. Collectively, these factors are expected to boost the market for balloon catheters during the forecast period from 2025 to 2032.

Balloon Catheters Market Dynamics:

According to recent data from the British Heart Foundation (2025), an estimated 640 million people worldwide approximately 1 in 12 individuals were living with heart and circulatory diseases. Further data from the British Heart Foundation (2024) highlighted that coronary (ischemic) heart disease was the most commonly diagnosed cardiovascular condition globally, affecting around 200 million people, including approximately 110 million men and 80 million women. Additionally, there were about 56 million female and 45 million male stroke survivors globally. Moreover, at least 13 million individuals lived with congenital heart disease, with millions potentially remaining undiagnosed.

The increasing global prevalence of cardiovascular disorders such as coronary artery disease, peripheral artery disease, and strokes is driving demand for effective, minimally invasive interventions. One such intervention is percutaneous transluminal coronary angioplasty (PTCA), which uses balloon catheters to open narrowed or blocked arteries and restore blood flow, thereby reducing the risk of heart attacks and strokes. As the burden of cardiovascular disease continues to rise, the number of PTCA and PCI procedures is expected to grow, directly fueling the demand for PTCA balloon catheters and supporting market expansion.

Beyond cardiovascular applications, balloon catheters also play a critical role in managing cancer-related complications. According to GLOBOCAN (2022), there were approximately 435,000 new cases of kidney cancer globally, a number projected to rise to 693,000 by 2045. Similarly, new bladder cancer cases were estimated at 614,000 in 2022, with projections reaching 1.12 million by 2045. Cancers in the pelvic region can obstruct the ureters, impairing urine flow from the kidneys to the bladder. This leads to a buildup of urine and potential kidney damage. In such cases, nephrostomy procedures are performed, often requiring nephrostomy balloon catheters to create a passage for urine drainage. As the incidence of pelvic cancers rises, the demand for these devices is expected to increase, contributing further to the growth of the global balloon catheter market.

Additionally, ongoing product innovation and regulatory approvals are boosting market momentum. For example, in July 2024, Teleflex Incorporated received FDA 510(k) clearance for its Ringer(TM) Perfusion Balloon Catheter (PBC) the only commercially available PTCA perfusion balloon catheter. Featuring a rapid-exchange design and helical balloon that forms a hollow cylinder when inflated, the device allows continuous coronary blood flow during prolonged inflations and is used for dilating coronary arteries or bypass graft stenoses where distal perfusion is necessary.

However, the market does face challenges. Risks associated with balloon catheter procedures such as arterial dissection, vessel perforation, or embolism can lead to serious complications. Moreover, increasing product recalls due to quality and safety issues may hinder future market growth.

In summary, while the global balloon catheters market is poised for significant growth due to rising cardiovascular and cancer cases and increasing innovation, ongoing vigilance regarding device safety and quality remains critical to sustaining long-term market expansion.

Balloon Catheters Market Segment Analysis:

Balloon Catheters Market by Product Type (PTA, PTCA, Occlusion, Foley, Nephrostomy, Drug-Eluting, and Others), Catheter Type (Fixed Wire, Over-The-Wire, and Rapid Exchange), Balloon Type (Non-Compliant, Semi-Compliant, and Compliant), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the balloon type segment of the balloon catheters market, the non-compliant balloon catheter category is expected to hold the largest share in the year 2024. Non-compliant balloons maintain their shape and size, providing a more predictable and controlled dilation of narrowed or obstructed vessels. This characteristic makes them particularly valuable in high-pressure applications, such as in the treatment of coronary artery disease, where precise balloon sizing is critical in achieving optimal results without damaging the surrounding tissue. The enhanced performance of non-compliant balloons leads to better outcomes in procedures like angioplasty, reducing the risk of complications such as balloon rupture or vessel trauma. As healthcare providers increasingly recognize the benefits of these specialized devices, the demand for non-compliant balloon catheters has grown.

Additionally, advancements in material technology and design are making non-compliant balloons more effective and versatile, further driving their adoption across various medical fields. This shift towards non-compliant balloon catheters not only enhances procedural success rates but also supports the expansion of the balloon catheter market as a whole. For instance, in September 2023, Kossel Medtech's Sabelly(R) non-compliant peripheral balloon dilatation catheter received market approval from China's NMPA. Designed for angioplasty in the peripheral vascular system, it became the first domestically produced large-diameter balloon catheter approved, helping to reduce reliance on imported products.

Hence, all the above-mentioned factors are expected to generate considerable revenue for the segment pushing the overall growth of the global balloon catheters market during the forecast period.

North America is expected to dominate the overall balloon catheter market:

Among all the regions, North America is expected to hold the largest share of the global balloon catheters market in 2024. The key driving factors of the balloon catheters market are the increasing prevalence of brain aneurysms, urological disorders such as bladder cancers, benign prostatic hyperplasia, urinary retention, increasing prevalence of lifestyle disorders leading to the development of various cardiovascular diseases as well as growing focus on product development activities in the region. Collectively, these factors are expected to boost the overall market of balloon catheters across the region.

As per the data stated by the American Heart Association (2023), over 500,000 percutaneous coronary interventions were performed in the United States annually of which percutaneous transluminal coronary angioplasty holds a considerable share. Therefore, the rising prevalence of cardiovascular disorders as well as the subsequent increase in the number of PCI procedures being performed are further expected to boost the demand for scoring and cutting balloon catheters. This is estimated to contribute to the regional growth of the balloon catheters market in North America.

Another factor contributing to the regional growth of the North America balloon catheters market is the rising prevalence of brain aneurysms in the country. As per the statistics provided by the Brain Aneurysm Foundation (2023), approximately 30,000 people in the country suffer from a brain aneurysm rupture each year. In another set of data provided by the American Cancer Society, in 2023, it has been estimated that approximately 24,350 malignant tumors of the brain or spinal cord may occur in the US. It also estimated that in 2023, approximately 18,600 people were expected to succumb to brain and spinal cord tumors in the country. These indications are usually treated with occlusion balloon catheters specially devised for the administration in the neurovasculature. Therefore, the rising prevalence of brain aneurysms is also expected to drive the demand for such catheters, eventually boosting the growth of the market for balloon catheters in North America.

Additionally, product development activities across the region are further expected to boost the overall market of balloon catheters across the region. For instance, in August 2023, Shanghai MicroPort Medical (MicroPort(R) Coronary) received FDA approval for its Firefighter(TM) NC Pro PTCA Balloon Catheter. This next-generation high-pressure balloon was designed for dilating narrowed coronary arteries and post-stent procedures. With a three-layer composite balloon and a burst pressure of up to 22 atm, it effectively treated resistant lesions like calcifications.

Therefore, the factors mentioned above in the region are expected to boost the North America balloon catheters market during the forecast period.

Balloon Catheters Market Key Players:

Some of the key market players operating in the balloon catheters market include Medtronic, Boston Scientific Corporation, Abbott, Cook, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, Stryker, Teleflex Incorporated, Microport Scientific Corporation, BIOTRONIK, Nipro Medical Corporation, BD, Coloplast, Summit Medical (Innovia Medical) Well Lead Medical Co., Ltd., Smiths Medical, BACTIGUARD AB, JOTEC GmbH, Lepu Medical Technology(Beijing)Co., Ltd., and others.

Recent Developmental Activities in the Balloon Catheters Market:

  • In March 2024, Boston Scientific Corporation announced the approval of the FDA for the AGENT(TM) Drug-Coated Balloon (DCB) catheter, which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease.
  • In May 2022, Medtronic announced the approval from the U.S. Food and Drug Administration (FDA) for the IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, a drug-coated balloon (DCB), indicated for the interventional treatment of peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries.

Key takeaways from the balloon catheters market report study:

  • Market size analysis for current balloon catheters size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the balloon catheters market.
  • Various opportunities available for the other competitors in the balloon catheters market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current balloon catheter market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for balloon catheter market growth in the coming future?

Target audience who can benefit from this balloon catheter market report study:

  • Balloon catheter product providers
  • Research organizations and consulting companies
  • Balloon catheters-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in balloon catheters
  • Various end-users who want to know more about the balloon catheters market and the latest technological developments in the balloon catheters market.

Frequently Asked Questions for the Balloon Catheters Market:

1. What are balloon catheters?

  • A balloon catheter is a type of soft catheter that has a balloon attached at the tip of the catheter. This type of catheter is used in various minimally invasive diagnostic and therapeutic procedures such as opening of blockages, dilating vessels, and stent delivery among others.

2. What is the market for balloon catheters?

  • The balloon catheters market was valued at USD 4,972.01 million in 2024, growing at a CAGR of 7.63% during the forecast period from 2025 to 2032, to reach USD 8,928.76 million by 2032.

3. What are the drivers for the balloon catheter market?

  • The rising prevalence of cardiovascular diseases, brain aneurysms, and pelvic region cancers is significantly boosting the market for balloon catheters. As cardiovascular conditions become more common, the demand for balloon catheters increases. Additionally, balloon catheters are vital in managing brain aneurysms and enhancing drug delivery in pelvic cancers. Concurrently, advancements in product development by key market players are leading to innovative technologies, such as drug-eluting and bioresorbable balloons. These combined factors are driving the balloon catheter market as healthcare providers seek effective solutions to address the growing clinical needs of diverse patient populations. Collectively, these factors are expected to boost the market for balloon catheters during the forecast period from 2025 to 2032.

4. Who are the key players operating in the balloon catheters market?

  • Some of the key market players operating in the balloon catheters market include Medtronic, Boston Scientific Corporation, Abbott, Cook, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, Stryker, Teleflex Incorporated, Microport Scientific Corporation, BIOTRONIK, Nipro Medical Corporation, BD, Coloplast, Summit Medical (Innovia Medical) Well Lead Medical Co., Ltd., Smiths Medical, BACTIGUARD AB, JOTEC GmbH, Lepu Medical Technology(Beijing)Co., Ltd., and others.

5. Which region has the highest share in the balloon catheters market?

  • Among all the regions, North America is expected to hold the largest share of the global balloon catheters market in 2024. The key driving factors of the balloon catheters market are the increasing prevalence of brain aneurysms, urological disorders such as bladder cancers, benign prostatic hyperplasia, urinary retention, increasing prevalence of lifestyle disorders leading to the development of various cardiovascular diseases as well as growing focus on product development activities in the region. Collectively, these factors are expected to boost the overall market of balloon catheters across the region.

Table of Contents

1. Balloon Catheters Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Balloon Catheters Market Executive Summary

  • 2.1 Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1 The United States
  • 4.2 Europe
  • 4.3 Japan
  • 4.4 China

5. Balloon Catheters Market Key Factors Analysis

  • 5.1. Balloon Catheters Market Drivers
    • 5.1.1 Rising prevalence of cardiovascular diseases
    • 5.1.2 Growing prevalence of brain aneurysms
    • 5.1.3 Increasing prevalence of cancers in the pelvic region
    • 5.1.4 Increase in product development activities by key market players across the globe.
  • 5.2 Balloon Catheters Market Restraints and Challenges
    • 5.2.1 Surgical risk associated with balloon catheters
    • 5.2.2 The increased number of product recalls
  • 5.3 Balloon Catheters Market Opportunities
    • 5.3.1 Ongoing improvement in safety prospects and design-related shortcomings in balloon catheters

6. Balloon Catheters Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Balloon Catheters Market Assessment

  • 7.1 By Product Type
    • 7.1.1 PTA Balloon Catheters
    • 7.1.2 PTCA Balloon Catheters
    • 7.1.3 Occlusion Balloon Catheters
    • 7.1.4 Foley Catheters
    • 7.1.5 Nephrostomy Balloon Catheters
    • 7.1.6 Drug-Eluting Catheters
    • 7.1.7 Others
  • 7.2 By Catheter Type
    • 7.2.1 Fixed Wire
    • 7.2.2 Over-the-Wire
    • 7.2.3 Rapid Exchange
  • 7.3 By Balloon Type
    • 7.3.1 Non-Compliant
    • 7.3.2 Semi-Compliant
    • 7.3.3 Compliant
  • 7.4 By End-User
    • 7.4.1 Hospitals
    • 7.4.2 Specialty Clinics
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.1.2 Canada Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.1.3 Mexico Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.2 Europe
      • 7.5.2.1 France Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.2.2 Germany Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.2.3 United Kingdom Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.2.4 Italy Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.2.5 Spain Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.2.6 Rest of Europe Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.3.2 Japan Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.3.3 India Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.3.4 Australia Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.3.5 South Korea Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.3.6 Rest of Asia-Pacific Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1 Middle East Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.4.2 Africa Balloon Catheters Market Size in USD Million (2022-2032)
      • 7.5.4.3 South America Balloon Catheters Market Size in USD Million (2022-2032)

8. Balloon Catheters Market Company and Product Profiles

  • 8.1 Medtronic
    • 8.1.1 Company Overview
    • 8.1.2 Company Snapshot
    • 8.1.3 Financial Overview
    • 8.1.4 Product Listing
    • 8.1.5 Entropy
  • 8.2 Boston Scientific Corporation
    • 8.2.1 Company Overview
    • 8.2.2 Company Snapshot
    • 8.2.3 Financial Overview
    • 8.2.4 Product Listing
    • 8.2.5 Entropy
  • 8.3 Abbott
    • 8.3.1 Company Overview
    • 8.3.2 Company Snapshot
    • 8.3.3 Financial Overview
    • 8.3.4 Product Listing
    • 8.3.5 Entropy
  • 8.4 Cook
    • 8.4.1 Company Overview
    • 8.4.2 Company Snapshot
    • 8.4.3 Financial Overview
    • 8.4.4 Product Listing
    • 8.4.5 Entropy
  • 8.5 B. Braun Melsungen AG
    • 8.5.1 Company Overview
    • 8.5.2 Company Snapshot
    • 8.5.3 Financial Overview
    • 8.5.4 Product Listing
    • 8.5.5 Entropy
  • 8.6 Cardinal Health
    • 8.6.1 Company Overview
    • 8.6.2 Company Snapshot
    • 8.6.3 Financial Overview
    • 8.6.4 Product Listing
    • 8.6.5 Entropy
  • 8.7 Terumo Corporation
    • 8.7.1 Company Overview
    • 8.7.2 Company Snapshot
    • 8.7.3 Financial Overview
    • 8.7.4 Product Listing
    • 8.7.5 Entropy
  • 8.8 Stryker
    • 8.8.1 Company Overview
    • 8.8.2 Company Snapshot
    • 8.8.3 Financial Overview
    • 8.8.4 Product Listing
    • 8.8.5 Entropy
  • 8.9 Teleflex Incorporated
    • 8.9.1 Company Overview
    • 8.9.2 Company Snapshot
    • 8.9.3 Financial Overview
    • 8.9.4 Product Listing
    • 8.9.5 Entropy
  • 8.10. Microport Scientific Corporation
    • 8.10.1 Company Overview
    • 8.10.2 Company Snapshot
    • 8.10.3 Financial Overview
    • 8.10.4 Product Listing
    • 8.10.5 Entropy
  • 8.11. BIOTRONIK
    • 8.11.1 Company Overview
    • 8.11.2 Company Snapshot
    • 8.11.3 Financial Overview
    • 8.11.4 Product Listing
    • 8.11.5 Entropy
  • 8.12. Nipro Medical Corporation
    • 8.12.1 Company Overview
    • 8.12.2 Company Snapshot
    • 8.12.3 Financial Overview
    • 8.12.4 Product Listing
    • 8.12.5 Entropy
  • 8.13. BD
    • 8.13.1 Company Overview
    • 8.13.2 Company Snapshot
    • 8.13.3 Financial Overview
    • 8.13.4 Product Listing
    • 8.13.5 Entropy
  • 8.14. Coloplast
    • 8.14.1 Company Overview
    • 8.14.2 Company Snapshot
    • 8.14.3 Financial Overview
    • 8.14.4 Product Listing
    • 8.14.5 Entropy
  • 8.15. Summit Medical (Innovia Medical)
    • 8.15.1 Company Overview
    • 8.15.2 Company Snapshot
    • 8.15.3 Financial Overview
    • 8.15.4 Product Listing
    • 8.15.5 Entropy
  • 8.16. Well Lead Medical Co., Ltd.
    • 8.16.1 Company Overview
    • 8.16.2 Company Snapshot
    • 8.16.3 Financial Overview
    • 8.16.4 Product Listing
    • 8.16.5 Entropy
  • 8.17. Smiths Medical
    • 8.17.1 Company Overview
    • 8.17.2 Company Snapshot
    • 8.17.3 Financial Overview
    • 8.17.4 Product Listing
    • 8.17.5 Entropy
  • 8.18. BACTIGUARD AB
    • 8.18.1 Company Overview
    • 8.18.2 Company Snapshot
    • 8.18.3 Financial Overview
    • 8.18.4 Product Listing
    • 8.18.5 Entropy
  • 8.19. JOTEC GmbH
    • 8.19.1 Company Overview
    • 8.19.2 Company Snapshot
    • 8.19.3 Financial Overview
    • 8.19.4 Product Listing
    • 8.19.5 Entropy
  • 8.20. Lepu Medical Technology(Beijing)Co.,Ltd.
    • 8.20.1 Company Overview
    • 8.20.2 Company Snapshot
    • 8.20.3 Financial Overview
    • 8.20.4 Product Listing
    • 8.20.5 Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Balloon Catheters Market in Global (2022-2032)
  • Table 3: Balloon Catheters Market in Global by Product Type (2022-2032)
  • Table 4: Balloon Catheters Market in Global by Catheter Type (2022-2032)
  • Table 5: Balloon Catheters Market in Global by Balloon Type (2022-2032)
  • Table 6: Balloon Catheters Market in Global by End-User (2022-2032)
  • Table 7: Balloon Catheters Market in Global by Geography (2022-2032)
  • Table 8: Balloon Catheters Market in North America (2022-2032)
  • Table 9: Balloon Catheters Market in the United States (2022-2032)
  • Table 10: Balloon Catheters Market in Canada (2022-2032)
  • Table 11: Balloon Catheters Market in Mexico (2022-2032)
  • Table 12: Balloon Catheters Market in Europe (2022-2032)
  • Table 13: Balloon Catheters Market in France (2022-2032)
  • Table 14: Balloon Catheters Market in Germany (2022-2032)
  • Table 15: Balloon Catheters Market in United Kingdom (2022-2032)
  • Table 16: Balloon Catheters Market in Italy (2022-2032)
  • Table 17: Balloon Catheters Market in Spain (2022-2032)
  • Table 18: Balloon Catheters Market in the Rest of Europe (2022-2032)
  • Table 19: Balloon Catheters Market in Asia-Pacific (2022-2032)
  • Table 20: Balloon Catheters Market in China (2022-2032)
  • Table 21: Balloon Catheters Market in Japan (2022-2032)
  • Table 22: Balloon Catheters Market in India (2022-2032)
  • Table 23: Balloon Catheters Market in Australia (2022-2032)
  • Table 24: Balloon Catheters Market in South Korea (2022-2032)
  • Table 25: Balloon Catheters Market in Rest of Asia-Pacific (2022-2032)
  • Table 26: Balloon Catheters Market in the Rest of the World (2022-2032)
  • Table 27: Balloon Catheters Market in the Middle East (2022-2032)
  • Table 28: Balloon Catheters Market in Africa (2022-2032)
  • Table 29: Balloon Catheters Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Balloon Catheters Market in Global (2022-2032)
  • Figure 3: Balloon Catheters Market in Global by Product Type (2022-2032)
  • Figure 4: Balloon Catheters Market in Global by Catheter Type (2022-2032)
  • Figure 5: Balloon Catheters Market in Global by Balloon Type (2022-2032)
  • Figure 6: Balloon Catheters Market in Global by End-User (2022-2032)
  • Figure 7: Balloon Catheters Market in Global by Geography (2022-2032)
  • Figure 8: Balloon Catheters Market in North America (2022-2032)
  • Figure 9: Balloon Catheters Market in the United States (2022-2032)
  • Figure 10: Balloon Catheters Market in Canada (2022-2032)
  • Figure 11: Balloon Catheters Market in Mexico (2022-2032)
  • Figure 12: Balloon Catheters Market in Europe (2022-2032)
  • Figure 13: Balloon Catheters Market in France (2022-2032)
  • Figure 14: Balloon Catheters Market in Germany (2022-2032)
  • Figure 15: Balloon Catheters Market in United Kingdom (2022-2032)
  • Figure 16: Balloon Catheters Market in Italy (2022-2032)
  • Figure 17: Balloon Catheters Market in Spain (2022-2032)
  • Figure 18: Balloon Catheters Market in the Rest of Europe (2022-2032)
  • Figure 19: Balloon Catheters Market in Asia-Pacific (2022-2032)
  • Figure 20: Balloon Catheters Market in China (2022-2032)
  • Figure 21: Balloon Catheters Market in Japan (2022-2032)
  • Figure 22: Balloon Catheters Market in India (2022-2032)
  • Figure 23: Balloon Catheters Market in Australia (2022-2032)
  • Figure 24: Balloon Catheters Market in South Korea (2022-2032)
  • Figure 25: Balloon Catheters Market in Rest of Asia-Pacific (2022-2032)
  • Figure 26: Balloon Catheters Market in the Rest of the World (2022-2032)
  • Figure 27: Balloon Catheters Market in the Middle East (2022-2032)
  • Figure 28: Balloon Catheters Market in Africa (2022-2032)
  • Figure 29: Balloon Catheters Market in South America (2022-2032)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER'S Five Force Analysis